Polymyxin b Sulphate Injection Manufacturers  In India | Third Party Manufacturers For Polymyxin b Sulphate Injection Manufacturers | Polymyxin b Sulphate injectable Manufacturers Chandigarh, Baddi, Nalaghar, Kala Amb, Una, Solan, Paonta Sahib, Roorkee, Haridwar, RIshikesh, Ahmedabad, Banglore, Mumbai, Punjab, Haryana, Himachal Pradesh, India.

Renal Function Should Be Carefully Determined And Patients With Renal Damage And Nitrogen Retention Should Have Reduced Dosage. Patients With Nephrotoxicity Due To Polymyxin B Sulfate Usually Show Albuminuria, Cellular Casts, And Azotemia. Diminishing Urine Output And A Rising Bun Are Indications For Discontinuing Therapy With This Drug.

Neurotoxic Reactions May Be Manifested By Irritability, Weakness, Drowsiness, Ataxia, Perioral Paresthesia, Numbness Of The Extremities, And Blurring Of Vision. These Are Usually Associated With High Serum Levels Found In Patients With Impaired Renal Function And/Or Nephrotoxicity.

The Concurrent Or Sequential Use Of Other Neurotoxic And/Or Nephrotoxic Drugs With Polymyxin B Sulfate, Particularly Bacitracin, Streptomycin, Neomycin, Kanamycin, Gentamicin, Tobramycin, Amikacin, Cephaloridine, Paromomycin, Viomycin, And Colistin Should Be Avoided.

The Neurotoxicity Of Polymyxin B Sulfate Can Result In Respiratory Paralysis From Neuromuscular Blockade, Especially When The Drug Is Given Soon After Anesthesia And/Or Muscle Relaxants.

Usage In Pregnancy: The Safety Of This Drug In Human Pregnancy Has Not Been Established.